KAYLA JOHNSON: Open Payments
NPI 1255839858 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,800 in 91 payments from 14 companies in 2025. Trend: 2023 $1,912 · 2024 $2,041 · 2025 $1,800
Food & beverage: $1,800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $421 |
| UCB, Inc. | 16 | $356 |
| Amgen Inc. | 19 | $290 |
| E.R. Squibb & Sons, L.L.C. | 13 | $284 |
| Mallinckrodt Hospital Products Inc. | 4 | $100 |
| PFIZER INC. | 4 | $87 |
| Abbott Laboratories | 2 | $75 |
| Janssen Biotech, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
Products named: Bimzelx, ORENCIA, RINVOQ, SKYRIZI, OTEZLA, ACTHAR, XELJANZ, ENBREL.
Industry payments across AR — which companies pay providers there.
